The Influence of Standardized Process Management of Laryngeal Mask Airway Placement Based on Pressure Monitoring on the Incidence of Adverse Reactions in Elderly Patients During the Perioperative Period

Recruiting N/A Interventional Study
LMA Pressure Injury Elderly Airway Management
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
60 and older
Sex
Any
Study type
Interventional
Purpose
Prevention
Participants needed
78 (estimated)
Sponsor
Xuanqi Yang · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The laryngeal mask airway (LMA) is a supraglottic ventilation device designed according to human anatomy. It was developed in 1981 by Dr. Archie Boubrain in the United Kingdom to compensate for the deficiencies of tracheal intubation and mask ventilation. It has been widely used in clinical practice because of its simple operation, small airway stimulation, and hemodynamic stability. In 1990, LMA …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age ≥60 years old * Non-cardiothoracic surgery and head and neck surgery * Elective surgery * ASA I-III grade * NYHA cardiac function class I-II * The operation time is expected to be ≥30 minutes and ≤2 hours * 18.5≤BMI (kg/m2) ≤24.9 Exclusion Criteria: * Change to emergency…
Contacts

Xuanqi Yang

+8613408631952

734357421@qq.com

CONTACT